Clicky

Viatris Inc.(VTRS) News

Date Title
Apr 18 3 Generic Drug Stocks to Watch Amid Challenging Market Prospects
Apr 18 Bill Miller’s Latest 13 Stock Picks
Apr 16 Viatris to Report First Quarter 2024 Financial Results on May 9, 2024
Apr 15 Viatris Appoints Corinne Le Goff as Chief Commercial Officer
Apr 15 Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in Canada
Apr 4 Competition watchdog says HRT drug deal could raise prices
Apr 4 UPDATE 1-UK watchdog says Theramex-Viatris deal raises competition concerns
Apr 1 UPDATE 1-Teva, Viatris win new chance to challenge J&J schizophrenia drug patent
Apr 1 Teva, Viatris win new chance to challenge J&J schizophrenia drug patent
Apr 1 Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris
Apr 1 Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United States
Mar 29 Why Is Viatris (VTRS) Down 3.5% Since Last Earnings Report?
Mar 27 Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline
Mar 14 Is Viatris a Great Dividend Stock or Just a Value Trap?
Mar 11 2 Dirt Cheap Dividend Stocks to Buy and Hold
Mar 11 UPDATE 1-US FDA declines to approve Viatris's injection for multiple sclerosis
Mar 8 Viatris Inc's Dividend Analysis
Mar 6 Insider Sell: President of Greater China Xiangyang Ni Sells 21,532 Shares of Viatris Inc (VTRS)
Mar 5 Viatris Inc. (NASDAQ:VTRS) Q4 2023 Earnings Call Transcript
Mar 5 13 Best Pharma Dividend Stocks To Buy in 2024